Induction of somatic mutation and recombination by four inhibitors of eukaryotic topoisomerases assayed in the wing spot test of Drosophila melanogaster

Mutagenesis

Volumn 11, Issue 4, 1996, Pages 315-325

  Frei, Hansjörg ^a   Würgler, Friedrich E ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ELLIPTICINE; EPIPODOPHYLLOTOXIN; ETOPOSIDE; ISOMERASE INHIBITOR; TENIPOSIDE;

ANIMAL EXPERIMENT; ARTICLE; ASSAY; CONTROLLED STUDY; DNA RECOMBINATION; DROSOPHILA MELANOGASTER; GENOTOXICITY; MUTAGEN TESTING; NONHUMAN; PRIORITY JOURNAL; SOMATIC MUTATION;

ANIMALS; CAMPTOTHECIN; DNA TOPOISOMERASES, TYPE I; DROSOPHILA MELANOGASTER; ELLIPTICINES; ENZYME INHIBITORS; ETOPOSIDE; FEMALE; MALE; MUTAGENICITY TESTS; MUTATION; RECOMBINATION, GENETIC; TENIPOSIDE;

ANIMALIA; DROSOPHILA MELANOGASTER; EUKARYOTA; MELANOGASTER;

EID: 0030037728     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/11.4.315     Document Type: Article

References (60)

1. Agarwal, K., Mukherjee, A. and Sen, S. (1994) Etoposide (VP 16): cytogenetic studies in mice. Environ. Mol. Mutagen., 23, 190-193.
2. Becker, H.J. (1976) Mitotic recombination. In Ashburner, M. and Novitski, E. (eds), The Genetics and Biology of Drosophila. Academic Press, London, vol. 1c, pp. 1020-1087.
3. Bhuyan, B.K., Fraser, T.J. and Li, L.H. (1972) Cell cycle phase specificity and biochemical effects of ellipticine on mammalian cells. Cancer Res., 32, 2538-2544.
4. Buchenau, P., Saumweber, H. and Arndt-Jovin, D.J. (1993) Consequences of topoisomerase II inhibition in early embryogenesis of Drosophila revealed by in vivo confocal laser scanning microscopy. J. Cell Sci., 104, 1175-1185.
5. Chen, G.L., Yang, L., Rowe, T.C., Halligan, B.D., Tewey, K.M. and Liu, L.F. (1984) Non-intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem., 259, 13560-13566.
6. Clements, J. and Vogel, E.W. (1988) Somatic recombination and mutation assays in Drosophila: a comparison of the response of two different strains to four mutagens. Mutat. Res., 209, 1-5.
7. +/--3.7.2C mouse lymphoma cells. Mutat. Res., 187, 141-149.
8. DeMarini, D.M., Doerr, C.L., Meyer, M.K., Brock, K.H., Hozier, J. and Moore, M.M. (1987b) Mutagenicity of m-AMSA and o-AMSA in mammalian cells due to clastogenic mechanism: possible role of topoisomerase. Mutagenesis, 2, 349-355.
9. Dillehay, L.E., Denstman, S.C. and Williams, J.R. (1987) Cell cycle dependence of sister chromatid exchange induction by DNA topoisomerase II inhibitors in Chinese hamster V79 cells. Cancer Res., 47, 206-209.
10. Ferguson, L.R. and Baguley, B.C. (1994) Topoisomerase II enzymes and mutagenicity. Environ. Mol. Mutagen., 24, 245-261.
11. Ferguson, L.R. and Turner, P.M. (1988) Mitotic crossing-over by anticancer drugs in Saccharomyces cerevisiae strain D5. Mutat. Res., 204, 239-249.
12. Ferguson, L.R., Turner, P.M. and Baguley, B.C. (1993) Induction of mitotic crossing-over by the topoisomerase II poison DACA (N-[2-dimethylaminoethyl]acridine-4-carboxamide) in Saccharomyces cerevisiae. Mutat. Res., 289, 157-163.
13. Frei, H. and Würgler, F.E. (1988) Statistical methods to decide whether mutagenicity test data from Drosophila assays indicate a positive, negative, or inconclusive result. Mutat. Res., 203, 297-308.
14. Frei, H. and Würgler, F.E. (1995) Optimal experimental design and sample size for the statistical evaluation of data from somatic mutation and recombination tests (SMART) in Drosophila. Mutat. Res., 334, 247-258.
15. Frei, H., Würgler, F.E., Juon, H., Hall, C.B. and Graf, U. (1985) Aristolochic acid is mutagenic and recombinogenic in Drosophila genotoxicity tests. Arch. Toxicol., 56, 158-166.
16. Frei, H., Clements, J., Howe, D. and Würgler, F.E. (1992a) The genotoxicity of the anti-cancer drug mitoxantrone in somatic and germ cells of Drosophila melanogaster. Mutat. Res., 279, 21-33.
17. Frei, H., Lüthy, J., Brauchli, J., Zweifel, U., Würgler, F.E. and Schlatter, C. (1992b) Structure/activity relationships of the genotoxic potencies of sixteen pyrrolizidine alkaloids assayed for the induction of somatic mutation and recombination in wing cells of Drosophila melanogaster. Chem.-Biol. Interact., 83, 1-22.
18. Fukada, M. (1985) Action of camptothecin and its derivatives on deoxyribonucleic acid. Biochem. Pharmacol., 34, 1225-1230.
19. Gocke, E. (1991) Mechanism of quinolone mutagenicity in bacteria. Mutat. Res., 248, 135-143.
20. Graf, U., Würgler, F.E., Katz, A.J., Frei, H., Juon, H., Hall, C.B. and Kale, P.G. (1984) Somatic mutation and recombination test in Drosophila melanogaster. Environ. Mutagen., 6, 153-188.
21. Graf, U., Ok-Soon, H. and Olvera Ramirez, O. (1992) The genotoxicity of chromium(VI) oxide in the wing spot test of Drosophila melanogaster is over 90% due to mitotic recombination. Mutat. Res., 266, 197-203.
22. Gupta, R. (1990) Tests for the genotoxicity of m-AMSA, etoposide, teniposide and ellipticine in Neurospora crassa. Mutat. Res., 240, 47-58.
23. Gupta, R.S., Bromke, A., Bryant, D.W., Gupta, R., Singh, B. and McCalla, D.R. (1987) Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems. Mutagenesis, 2, 179-186.
24. Haynie, J.L. and Bryant, P.J. (1977) The effects of X-rays on the proliferation dynamics of cells in the imaginal wing disc of Drosophila melanogaster. Wilh. Roux Arch. Develop. Biol., 183, 85-100.
25. Hsiang, Y.-H., Hertzberg, R., Hecht, S. and Liu, L.F. (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem., 260, 14873-14878.
26. Hsieh, T.-S., Brown, S.D., Huang, P. and Fostel, J. (1992) Isolation and characterization of a gene encoding DNA topoisomerase I in Drosophila melanogaster. Nucleic Acids Res., 20, 6177-6182.
27. Huang, C.C., Hou, Y. and Wang, J.J. (1973) Effects of a new antitumor agent, epipodophyllotoxin, on growth and chromosomes in human hematopoietic cell lines. Cancer Res., 33, 3123-3129.
28. Hussy, P., Maass, G., Tümmler, B., Grosse, F. and Schomburg, U. (1986) Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase a primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob. Agents Chemother., 29, 1073-1078.
29. Kroeger, P.E. and Rowe, T.C. (1989) Interaction of topoisomerase I with the transcribed region of the Drosophila HSP 70 heat shock gene. Nucleic Acids Res., 17, 8495-8509.
30. Larsen, A.K., Grondard, L., Couprie, J., Desoize, B., Comoe, L., Jardillier, J.-C. and Riou, J.-F. (1993) The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II. Biochem. Pharmacol., 46, 1403-1412.
31. Lindsley, D.L. and Zimm, G.G., eds. (1992) The Genome of Drosophila melanogaster. Academic Press, San Diego, CA.
32. Liu, L.F. (1989) DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem., 58, 351-375.
33. Maraschin, J., Dutrillaux, B. and Aurias, A. (1990) Chromosome aberrations induced by etoposide (VP-16) are not random. Int. J. Cancer, 46, 808-812.
34. Marshall, B., Darkin, S. and Ralph, R.K. (1983) Evidence that mAMSA induces lopoisomerase action. FEBS Lett., 161, 75-78.
35. McCoy, E., Petrullo, L.A. and Rosenkranz, H.S. (1980) Non-mutagenic genotoxicants: novobiocin and nalidixic acid, 2 inhibitors of DNA gyrase. Mutat. Res., 79, 33-43.
36. +/--3.7.2C mouse lymphoma cells by the clastogen ellipticine. Environ. Mutagen., 9, 161-170.
37. Nakanomyo, H., Hiraoka, M. and Shiraya, M. (1986) Mutagenicity tests of etoposide and teniposide. J. Toxicol. Sci., 11(Suppl. I), 301-310.
38. Nitiss, J. and Wang, J.C. (1988) DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc. Natl. Acad. Sci. USA, 85, 7501-7505.
39. Osheroff, N. (1989a) Biochemical basis for the interactions of type I and type II topoisomerases with DNA. Pharmacol. Ther., 41, 223-241.
40. Osheroff, N. (1989b) Effect of antineoplastic agents on the DNA cleavage/ religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide. Biochemistry, 28, 6157-6160.
41. Pérez-Chiesa, Y. and Narvaez, Z. (1993) Evaluation of genotoxicity of the indenoisoquinoline analogues of fagaronine and nitidine in Drosophila melanogaster. Mutat. Res., 301, 207-212.
42. Pérez-Chiesa, Y. and Rodríguez, A. (1993) Absence of mutagenicity of benzo[c]phenantridine alkaloids in somatic cells of Drosophila melanogaster: comparison with 7,12-dimethylbenz[a]anthracene and chrysene. Mutat. Res., 298, 277-283.
43. Pezzuto, J.M., Antosiak, S.K., Messmer, W.M., Slaytor, M.B. and Honig, G.R. (1983) Interaction of the antileukemic alkaloid, 2-hydroxy-3,8,9-trimethoxy-5-methylbenzo[c]phenantridine (fagaronine), with nucleic acids. Chem.-Biol. Interact., 43, 323-339.
44. Pommier, Y., Schwartz, R.E., Kohn, K.W. and Zwelling, L.A. (1984) Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents. Biochemistry, 23, 3194-3201.
45. Ralph, R.K., Judd, W., Pommier, Y. and Kohn, K.W. (1994) DNA topoisomerases. In Neidle, S. and Waring, M. (eds), Molecular Aspects of Anticancer Drug-DNA Interactions. Macmillan, London, vol. 2, pp. 1-95.
46. Ramel, C. and Magnusson, J. (1992) Modulation of genotoxicity in Drosophila. Mutat. Res., 267, 221-227.
47. Robinson, M.J., Corbett, A.H. and Osheroff, N. (1993) Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II. Biochemistry, 32, 3638-3643.
48. Shelton, E.R., Osheroff, N. and Brutlag, D.L. (1983) DNA topoisomerase II from Drosophila melanogaster; purification and physical characterization. J. Biol. Chem., 258, 9530-9535.
49. Szabad, J., Soós, I., Polgár, G. and Héjja, G. (1983) Testing the mutagenicity of malondialdehyde and formaldehyde by the Drosophila mosaic and the sex-linked recessive lethal tests. Mutat. Res., 113, 117-133.
50. Takahashi, K., Kaneko, I., Nishiyama, C. and Nakano, K. (1985) Effect of novobiocin on the frequencies of chromatid-type aberrations and sister-chromatid exchanges following gamma-irradiation. Mutat. Res., 144, 265-270.
51. Takahashi, K., Kaneko, I. and Nishiyama, C. (1986) Increase in the frequency of γ-ray induced chromosomal aberrations in mammalian cells by post-treatment with novobiocin. Int. J. Radiat. Biol., 49, 657-663.
52. Vogel, E.W. and Nivard, M.J.M. (1993) Performance of 181 chemicals in a Drosophila assay predominantly monitoring interchromosomal mitotic recombination. Mutagenesis, 8, 57-81.
53. Wang, L.-K., Johnson, R.K. and Hecht, S.M. (1993) Inhibition of topoisomerase I function by nitidine and fagaronine. Chem. Res. Toxicol., 6, 813-818.
54. Wittig, B., Dorbic, T. and Rich, A. (1989) The level of Z-DNA in metabolically active, permeabilized mammalian cell nuclei is regulated by torsional strain. J. Cell Biol., 108, 755-764.
55. Würgler, F.E. and Vogel, E.W. (1986) In vivo mutagenicity testing using cells of Drosophila melanogaster. In De Serres, F.J. (ed.), Chemical Mutagens, Principles and Methods far their Detection. Plenum Press, New York, vol. 10, pp. 1-72.
56. Wyckoff, E., Natalie, D., Nolan, J.M., Lee, M. and Hsieh, T.-S. (1989) Structure of the Drosophila DNA topoisomerase II gene; nucleotide sequence and homology among topoisomerases II. J. Mol. Biol., 205, 1-13.
57. Zhang, H., Wang, J.C. and Liu, L.F. (1988) Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc. Natl. Acad. Sci. USA, 85, 1060-1064.
58. Zordan, M., Russo, A., Costa, R., Bianco, N., Beltrame, C. and Levis, A.G. (1990) A concerted approach to the study of aneuploidogenic properties of two chelating agents (EDTA and NTA) in the germ and somatic cell lines of Drosophila and the mouse. Environ. Mol. Mutagen., 15, 205-213.
59. Zordan, M., Graf, U., Singer, D., Beltrame, C., Dalla Valle, L., Osti, M., Costa, R. and Levis, A.G. (1991) The genotoxicity of nitrilotriacetic acid (NTA) in a somatic mutation and recombination test in Drosophila melanogaster. Mutat. Res., 262, 253-261.
60. Zordan, M., Osti, M., Pesce, M. and Costa, R. (1994) Chloral hydrate is recombinogenic in the wing spot test in Drosophila melanogaster. Mutat. Res., 322, 111-116.